June 2014 – The CenterWatch Monthly : PDF
CRO market poised for growth and consolidation
CROs have seen strong financial results during the past 18 months, reporting higher revenue and a rebound in profit margins, and they expect another year of healthy growth fueled by strategic partnerships with sponsors and an increase in clinical outsourcing.
Strategies for success evolving in phase I space
Nathan Segall, M.D., had high expectations when he opened his phase I clinical trial unit in Atlanta. So did Chad Jaeger, when his employer, Da Vita Clinical Research, expanded in Denver.
Also in this issue:
- Country and site selection: Best practices
- Navigating mobile regulations in clinical trials
- Regulatory Update
- Month in Review
- FDA Actions
- Study Lead Opportunities
- New Drugs in the Pipeline